KP Tissue Inc. (TSE:KPT – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$11.68 and traded as high as C$12.93. KP Tissue shares last traded at C$12.80, with a volume of 5,491 shares changing hands.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. TD boosted their price objective on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Desjardins increased their price objective on KP Tissue from C$12.00 to C$12.50 and gave the company a “hold” rating in a research report on Friday, May 15th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of C$12.12.
Read Our Latest Report on KP Tissue
KP Tissue Trading Up 0.8%
KP Tissue (TSE:KPT – Get Free Report) last issued its earnings results on Thursday, May 14th. The company reported C$0.22 earnings per share (EPS) for the quarter. As a group, analysts forecast that KP Tissue Inc. will post 0.4398964 earnings per share for the current fiscal year.
KP Tissue Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 15th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 6.5%. The ex-dividend date of this dividend was Tuesday, June 30th. KP Tissue’s payout ratio is currently 80.00%.
Insider Activity at KP Tissue
In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the company’s stock in a transaction on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total transaction of C$48,784.40. Following the completion of the sale, the director owned 15,712 shares in the company, valued at approximately C$208,969.60. The trade was a 18.93% decrease in their position. In the last three months, insiders have sold 6,668 shares of company stock worth $87,644. Insiders own 0.14% of the company’s stock.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Further Reading
- Five stocks we like better than KP Tissue
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
